Renal Damage Frequency in Patients with Solitary Kidney and Factors That Affect Progression

Table 4

Clinical features of unilateral renal agenesis/dysplasia patients at presentation.

	Group 2a (: 18); CKD (+)	Group 2b (: 13); CKD (−)
Age (years)	47.22 ± 13.09	40.08 ± 12.47	NS
Gender M/F	7/11	6/7	NS
BMI kg/m^2	27 ± 4.583	21	NS
Kidney size cm	115.81 ± 20.40	123.91 ± 11.08	NS
Duration of follow-up (months)	51.33 ± 35.56	30.62 ± 20.18	NS
SBP mmHg	133.33 ± 26.78	126.15 ± 22.18	NS
DBP mmHg	82.78 ± 15.26	78.38 ± 7.89	NS
GFR (initial) mL/min/1.73 m^2	44.72 ± 21.39	84 ± 21.72	NS
GFR (last) mL/min/1.73 m^2	42.17 ± 29.32	85.77 ± 22.21	NS
Proteinuria (initial) g/24 h	1.53 ± 1.75	0.056 ± 0.06	0.014
Proteinuria (last) g/24 h	1.30 ± 1.44	0.089 ± 0.10	0.014
Creatinine (initial) mg/dL	2.01 ± 1.19	0.94 ± 0.16	NS
Creatinine (last) mg/dL	2.49 ± 1.72	0.93 ± 0.18	NS
Uric acid (initial) mg/dL	6.8 ± 2.1	5.3 ± 1.1	0.032
Uric acid (last) mg/dL	6.0 ± 1.6	5.2 ± 1.1	NS
Diabetes mellitus	5 (27.8%)	0	0.038
Hypertension	15 (83.3%)	6 (46.2%)	0.003
RAS blockade	10 (55.5%)	6 (46.2%)	NS